AstraZeneca PLC (AZN)
182.58
-2.34
(-1.27%)
USD |
NYSE |
May 07, 16:00
182.00
-0.58
(-0.32%)
After-Hours: 20:00
AstraZeneca SG&A Expense (TTM) : 585.31M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| GSK Plc | 12.24B |
| Amgen, Inc. | 6.965B |
| Biogen, Inc. | 2.468B |
| Gilead Sciences, Inc. | 8.398B |
| Moderna, Inc. | 979.00M |